Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Abstract Objectives The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVEC) and mitomycin‐C (MMC) at our institution. Patients an...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto, Aidan P. Noon
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Wiley 2023-05-01
Σειρά:BJUI Compass
Θέματα:
acceptability
high risk
hyperthermic intravesical chemotherapy
intravesical treatment
mitomycin C
non‐muscle‐invasive bladder cancer
Διαθέσιμο Online:https://doi.org/10.1002/bco2.203

Διαδίκτυο

https://doi.org/10.1002/bco2.203

Παρόμοια τεκμήρια